Tower Research Capital (TRC)’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,792
| Closed | -$13.9K | – | 5345 |
|
|
2025
Q1 | $13.9K | Buy |
1,792
+1,692
| +1,692% | +$13.1K | ﹤0.01% | 3323 |
|
|
2024
Q4 | $2.27K | Sell |
100
-706
| -88% | -$16K | ﹤0.01% | 4876 |
|
|
2024
Q3 | $4.51K | Buy |
806
+174
| +28% | +$973 | ﹤0.01% | 4520 |
|
|
2024
Q2 | $8.48K | Buy |
632
+166
| +36% | +$2.23K | ﹤0.01% | 4346 |
|
|
2024
Q1 | $8.1K | Buy |
466
+235
| +102% | +$4.09K | ﹤0.01% | 4080 |
|
|
2023
Q4 | $4.75K | Buy |
231
+104
| +82% | +$2.14K | ﹤0.01% | 4918 |
|
|
2023
Q3 | $2.11K | Buy |
+127
| New | +$2.11K | ﹤0.01% | 5213 |
|
|
2022
Q2 | – | Sell |
-354
| Closed | -$13K | – | 6192 |
|
|
2022
Q1 | $13K | Buy |
354
+170
| +92% | +$6.24K | ﹤0.01% | 3976 |
|
|
2021
Q4 | $10K | Buy |
184
+30
| +19% | +$1.63K | ﹤0.01% | 4556 |
|
|
2021
Q3 | $12K | Buy |
154
+130
| +542% | +$10.1K | ﹤0.01% | 4141 |
|
|
2021
Q2 | $20K | Sell |
24
-2
| -8% | -$1.67K | ﹤0.01% | 3881 |
|
|
2021
Q1 | $22K | Buy |
+26
| New | +$22K | ﹤0.01% | 3805 |
|
|
2020
Q4 | – | Sell |
-80
| Closed | -$97K | – | 5198 |
|
|
2020
Q3 | $97K | Buy |
80
+46
| +135% | +$55.8K | ﹤0.01% | 3165 |
|
|
2020
Q2 | $12K | Hold |
34
| – | – | ﹤0.01% | 3922 |
|
|
2020
Q1 | $16K | Buy |
+34
| New | +$16K | ﹤0.01% | 1814 |
|
|
2019
Q2 | – | Sell |
-12
| Closed | -$50K | – | 3858 |
|
|
2019
Q1 | $50K | Sell |
12
-2
| -14% | -$8.33K | ﹤0.01% | 1770 |
|
|
2018
Q4 | $43K | Buy |
14
+10
| +250% | +$30.7K | ﹤0.01% | 1383 |
|
|
2018
Q3 | $24K | Hold |
4
| – | – | ﹤0.01% | 2215 |
|
|
2018
Q2 | $15K | Buy |
4
+1
| +33% | +$3.75K | ﹤0.01% | 2586 |
|
|
2018
Q1 | $13K | Buy |
+3
| New | +$13K | ﹤0.01% | 2356 |
|
|
2017
Q4 | – | Sell |
-5
| Closed | -$24K | – | 3685 |
|
|
2017
Q3 | $24K | Buy |
+5
| New | +$24K | ﹤0.01% | 2613 |
|